Delivery Order SPE2DB24D2205-SPE2DB25FEHZM
Award Date 9/24/25
Potential Completion Date 10/16/25
Potential Value $45K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on August 25, 2025, for IMBRUVICA 140 MG tablets in a quantity of 28 units. This is a firm fixed-price, non-set-aside contract with a ceiling value of $7,575.75 and an ultimate completion date of September 16, 2025. The delivery order is being performed at the company's corporate office location in Conshohocken, PA. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $15,151.52 to AmerisourceBergen Drug Corp for the supply of Imbruvica 280 mg tablets (28-count) under a firm fixed price contract. This non-set-aside award, issued on July 17, 2025, with an ultimate completion date of August 7, 2025, represents a pharmaceutical procurement supporting federal medical supply requirements. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical...
- The Defense Logistics Agency awarded a $7,575.75 delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Imbruvica 420 mg tablets (28-count units). This is a firm fixed price, non-set-aside contract with an ultimate completion date of September 9, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a $8,116.87 firm fixed-price delivery order from the Defense Logistics Agency (DLA) on September 19, 2025, for the supply of Imbruvica 140 mg capsules (90-count units). This non-set-aside, competitively awarded delivery order is scheduled for completion by October 10, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX),...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Imbruvica 420 mg tablets (28-count) with a ceiling value of $76,839.82. This firm fixed-price delivery order, with an ultimate completion date of September 9, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will...
- The Defense Logistics Agency awarded a $15,151.52 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Imbruvica 420 mg tablets (28-count units). The contract, which is a non-set-aside competitive award, is scheduled for completion by October 17, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor based in Conshohocken, Pennsylvania, received a $8,116.87 delivery order award from the Defense Logistics Agency on September 10, 2025, for IMBRUVICA 140 mg capsules (90-count supply). The contract operates under firm fixed-price terms with an ultimate completion date of October 1, 2025, and was awarded competitively with no set-aside designation. This delivery order is a child contract issued against AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $15,151.52 to AmerisourceBergen Drug Corp for the supply of Imbruvica 420 mg tablets (quantity 28) on September 24, 2025, with an ultimate completion date of October 16, 2025. This firm fixed-price, competitively awarded contract carries no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 12, 2025, for the supply of Imbruvica 420 mg tablets (28-count units) with a ceiling value of $16,932.55. This firm fixed price delivery order, which carries an ultimate completion date of June 3, 2025, represents a non-competitive set-aside contract and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $30,303.04 to AmerisourceBergen Drug Corp for the supply of Imbruvica 420 mg tablets (28-count) with a firm fixed price contract type. The order is set to be completed by October 21, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. This is a non-set-aside competitive award issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...